BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 29425341)

  • 1. Fibroblast growth factor 23 is induced by an activated renin-angiotensin-aldosterone system in cardiac myocytes and promotes the pro-fibrotic crosstalk between cardiac myocytes and fibroblasts.
    Leifheit-Nestler M; Kirchhoff F; Nespor J; Richter B; Soetje B; Klintschar M; Heineke J; Haffner D
    Nephrol Dial Transplant; 2018 Oct; 33(10):1722-1734. PubMed ID: 29425341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGF23-Mediated Activation of Local RAAS Promotes Cardiac Hypertrophy and Fibrosis.
    Böckmann I; Lischka J; Richter B; Deppe J; Rahn A; Fischer DC; Heineke J; Haffner D; Leifheit-Nestler M
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrosis growth factor 23 is a promoting factor for cardiac fibrosis in the presence of transforming growth factor-β1.
    Kuga K; Kusakari Y; Uesugi K; Semba K; Urashima T; Akaike T; Minamisawa S
    PLoS One; 2020; 15(4):e0231905. PubMed ID: 32315372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor 23 modifies the pharmacological effects of angiotensin receptor blockade in experimental renal fibrosis.
    de Jong MA; Mirkovic K; Mencke R; Hoenderop JG; Bindels RJ; Vervloet MG; Hillebrands JL; van den Born J; Navis G; de Borst MH;
    Nephrol Dial Transplant; 2017 Jan; 32(1):73-80. PubMed ID: 27220755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.
    Leifheit-Nestler M; Große Siemer R; Flasbart K; Richter B; Kirchhoff F; Ziegler WH; Klintschar M; Becker JU; Erbersdobler A; Aufricht C; Seeman T; Fischer DC; Faul C; Haffner D
    Nephrol Dial Transplant; 2016 Jul; 31(7):1088-99. PubMed ID: 26681731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excessive fibroblast growth factor 23 promotes renal fibrosis in mice with type 2 cardiorenal syndrome.
    Hao H; Ma S; Zheng C; Wang Q; Lin H; Chen Z; Xie J; Chen L; Chen K; Wang Y; Huang X; Cao S; Liao W; Bin J; Liao Y
    Aging (Albany NY); 2021 Jan; 13(2):2982-3009. PubMed ID: 33460402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the implications of blocking renin-angiotensin-aldosterone system and fibroblast growth factor 23 in early left ventricular hypertrophy without chronic kidney disease.
    Watanabe K; Fujii H; Okamoto K; Kono K; Goto S; Nishi S
    Front Endocrinol (Lausanne); 2023; 14():1276664. PubMed ID: 38174329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Klotho and phosphate are modulators of pathologic uremic cardiac remodeling.
    Hu MC; Shi M; Cho HJ; Adams-Huet B; Paek J; Hill K; Shelton J; Amaral AP; Faul C; Taniguchi M; Wolf M; Brand M; Takahashi M; Kuro-O M; Hill JA; Moe OW
    J Am Soc Nephrol; 2015 Jun; 26(6):1290-302. PubMed ID: 25326585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
    Ding J; Tang Q; Luo B; Zhang L; Lin L; Han L; Hao M; Li M; Yu L; Li M
    Eur J Pharmacol; 2019 Sep; 859():172549. PubMed ID: 31325434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF23 activates injury-primed renal fibroblasts via FGFR4-dependent signalling and enhancement of TGF-β autoinduction.
    Smith ER; Holt SG; Hewitson TD
    Int J Biochem Cell Biol; 2017 Nov; 92():63-78. PubMed ID: 28919046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paracrine Effects of FGF23 on the Heart.
    Leifheit-Nestler M; Haffner D
    Front Endocrinol (Lausanne); 2018; 9():278. PubMed ID: 29892269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF23 promotes myocardial fibrosis in mice through activation of β-catenin.
    Hao H; Li X; Li Q; Lin H; Chen Z; Xie J; Xuan W; Liao W; Bin J; Huang X; Kitakaze M; Liao Y
    Oncotarget; 2016 Oct; 7(40):64649-64664. PubMed ID: 27579618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphate and FGF23 in the renoprotective benefit of RAAS inhibition.
    de Seigneux S; Martin PY
    Pharmacol Res; 2016 Apr; 106():87-91. PubMed ID: 26900884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Altered Mineral Metabolism on Pathological Cardiac Remodeling in Elevated Fibroblast Growth Factor 23.
    Leifheit-Nestler M; Richter B; Basaran M; Nespor J; Vogt I; Alesutan I; Voelkl J; Lang F; Heineke J; Krick S; Haffner D
    Front Endocrinol (Lausanne); 2018; 9():333. PubMed ID: 29977226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis.
    Barnes JW; Duncan D; Helton S; Hutcheson S; Kurundkar D; Logsdon NJ; Locy M; Garth J; Denson R; Farver C; Vo HT; King G; Kentrup D; Faul C; Kulkarni T; De Andrade JA; Yu Z; Matalon S; Thannickal VJ; Krick S
    Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L141-L154. PubMed ID: 31042083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of fibroblast growth factor 23 and Klotho in uremic cardiomyopathy.
    Grabner A; Faul C
    Curr Opin Nephrol Hypertens; 2016 Jul; 25(4):314-24. PubMed ID: 27219043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats.
    Leifheit-Nestler M; Grabner A; Hermann L; Richter B; Schmitz K; Fischer DC; Yanucil C; Faul C; Haffner D
    Nephrol Dial Transplant; 2017 Sep; 32(9):1493-1503. PubMed ID: 28339837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct and indirect effects of fibroblast growth factor 23 on the heart.
    Nakano T; Kishimoto H; Tokumoto M
    Front Endocrinol (Lausanne); 2023; 14():1059179. PubMed ID: 36909314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The axis of local cardiac endogenous Klotho-TGF-β1-Wnt signaling mediates cardiac fibrosis in human.
    Liu Q; Zhu LJ; Waaga-Gasser AM; Ding Y; Cao M; Jadhav SJ; Kirollos S; Shekar PS; Padera RF; Chang YC; Xu X; Zeisberg EM; Charytan DM; Hsiao LL
    J Mol Cell Cardiol; 2019 Nov; 136():113-124. PubMed ID: 31520610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the FGF23-Klotho axis.
    Olauson H; Vervloet MG; Cozzolino M; Massy ZA; Ureña Torres P; Larsson TE
    Semin Nephrol; 2014 Nov; 34(6):586-97. PubMed ID: 25498378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.